Clinical implications of serum autotoxin in regular follow up after pediatric living donor liver transplantation for biliary atresia

Study examines autotaxin as a serum biomarker for detecting graft fibrosis in pediatric patients following living donor liver transplantation for biliary atresia. Correlates autotaxin levels with histological findings during routine post-transplant follow-up to assess its clinical utility in monitoring graft health.